On Demand Webinars on Protein Sequencing - Rapid Novor

WebinarsIllia icherednychenko@rapidnovor.com2023-02-16T10:57:06-05:00

New Antibody Characterization Essentials from Discovery to Clinic

Tags: Antibody characterization, De novo sequencing, Featured, HDX-MS, Monoclonal antibody, Recombinant expression, REmAb, SPR, Technology|

Webinar

New Antibody Characterization Essentials from Discovery to Clinic

October 26

11:00 AM EST/8AM PST/3PM GMT

Discover the latest webinars.

Latest Advancements in Antibody Engineering – Bispecifics, Diagnostic Controls, and More

Illia icherednychenko@rapidnovor.com2023-11-09T13:19:41-05:00Tags: AbEng, Antibody engineering, Antibody generation, Application, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

Antibody Discovery Dead Ends and New Approaches

Illia icherednychenko@rapidnovor.com2023-08-24T15:35:59-04:00Tags: Antibody engineering, Antibody generation, Application, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

Rational Antibody Design and Engineering with Next Generation Protein Sequencing

Illia icherednychenko@rapidnovor.com2023-11-09T13:21:24-05:00Tags: AbEng, Antibody engineering, Antibody generation, Application, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

The Shortcut to Reliable Diagnostic, Control, and Assay Antibodies

Illia icherednychenko@rapidnovor.com2023-06-21T10:15:28-04:00Tags: Application, De novo sequencing, Featured, Learning, Monoclonal antibody, Polyclonal antibody, Recombinant expression, REmAb, REpAb, Technology|

Navigating Intellectual Property Protection for Antibodies

Illia icherednychenko@rapidnovor.com2023-06-21T10:21:38-04:00Tags: Antibody characterization, Antibody kinetics, Application, Featured, HDX-MS, Learning, Monoclonal antibody, REmAb, SPR|

Nanobody Lead Optimization with Epitope Mapping and Binning

Illia icherednychenko@rapidnovor.com2023-05-15T12:44:14-04:00Tags: Alpaca, Antibody characterization, Antibody kinetics, Application, Featured, Nanobody, Polyclonal antibody, REpAb, SPR, Technology, Vet med|

Selecting Specific Monoclonal Antibodies by SPR – Alpaca Antibody Showdown

Illia icherednychenko@rapidnovor.com2023-05-15T12:44:34-04:00Tags: Alpaca, Antibody characterization, Antibody discovery, Antibody kinetics, Application, Featured, Nanobody, Polyclonal antibody, REpAb, SPR, Technology, Vet med|

Characterizing Fragile Protein Complexes

Illia icherednychenko@rapidnovor.com2023-05-15T12:45:26-04:00Tags: Antibody characterization, Application, De novo sequencing, Featured, Monoclonal antibody, Proteomics, REmAb, Technology|

Next Generation Vaccine Development with Proteomics

Illia icherednychenko@rapidnovor.com2023-06-21T11:01:12-04:00Tags: Antibody characterization, Antibody engineering, Antibody therapeutics, Application, De novo sequencing, Featured, Monoclonal antibody, Proteomics, REmAb, Technology|

Enriching Engineered T Cells with Antibody Sequencing & Modulation

Illia icherednychenko@rapidnovor.com2023-06-21T10:59:48-04:00Tags: Antibody characterization, Antibody engineering, Application, De novo sequencing, Monoclonal antibody, Proteomics, REmAb, Technology|

Breakthrough Bispecific Antibody R&D Techniques

Illia icherednychenko@rapidnovor.com2023-05-15T12:49:14-04:00Tags: Antibody characterization, Antibody engineering, Antibody therapeutics, Application, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb|

Species-Agnostic Antibody Sequencing & Discovery in Veterinary Medicine R&D

Illia icherednychenko@rapidnovor.com2023-05-15T12:51:44-04:00Tags: Antibody characterization, Antibody discovery, Antibody engineering, Antibody therapeutics, Application, De novo sequencing, Proteomics, REmAb, Technology, Vet med|

Why Antibody Characterization Needs an Overhaul

Illia icherednychenko@rapidnovor.com2023-05-15T12:51:17-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Polyclonal antibody, Proteomics, REmAb|

Leveraging the Power of Next Generation Protein Sequencing to Shape Tomorrow’s In Vitro Diagnostics

Illia icherednychenko@rapidnovor.com2023-06-21T10:59:27-04:00Tags: Antibody characterization, Application, De novo sequencing, Monoclonal antibody, Proteomics, REmAb, Technology|

Why Is Sequence Blindness Acceptable with Antibodies?

Illia icherednychenko@rapidnovor.com2023-06-21T10:53:08-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Proteomics, Technology|

Recombinant Therapeutic pAbs are Now Possible

Illia icherednychenko@rapidnovor.com2023-06-21T10:58:13-04:00Tags: Antibody characterization, Antibody engineering, De novo sequencing, Learning, Proteomics, Recombinant expression, REmAb, Technology|

Polyclonal Antibody Sequencing in Therapeutics Development Pipelines

Illia icherednychenko@rapidnovor.com2023-06-21T10:58:31-04:00Tags: Antibody characterization, Antibody discovery, Antibody engineering, Application, De novo sequencing, Monoclonal antibody, Polyclonal antibody, Proteomics, REpAb, Technology|

Overcoming Irreproducibility in Life Science Research

Illia icherednychenko@rapidnovor.com2023-06-21T10:56:49-04:00Tags: Antibody characterization, Antibody engineering, De novo sequencing, Learning, Monoclonal antibody, Proteomics, Recombinant expression, REmAb, Technology|

Fully Harnessing the Power of Immunotherapy through Protein Sequencing

Illia icherednychenko@rapidnovor.com2023-06-21T10:58:53-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb, Technology|

DNA vs Next Generation Protein Sequencing – a Deep Dive

Illia icherednychenko@rapidnovor.com2023-06-21T10:57:04-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb, Technology|

Polyclonal Antibody Sequencing with Only Proteomics

Illia icherednychenko@rapidnovor.com2023-06-21T10:56:34-04:00Tags: Antibody characterization, Antibody discovery, De novo sequencing, Learning, Monoclonal antibody, Polyclonal antibody, Proteomics, REpAb, Technology|

Non-Fungible Antibodies

Illia icherednychenko@rapidnovor.com2023-06-21T10:57:53-04:00Tags: Antibody characterization, De novo sequencing, Learning, Proteomics, Recombinant expression, REmAb, Technology|

Leveraging pAbs for Therapeutic Development

Illia icherednychenko@rapidnovor.com2023-06-21T10:56:21-04:00Tags: Antibody characterization, Antibody discovery, Antibody therapeutics, De novo sequencing, Learning, Monoclonal antibody, Polyclonal antibody, Proteomics, REpAb, Technology|

Leveraging Polyclonal Antibody Sequencing to Get High Affinity Binders Against Tough Targets

Illia icherednychenko@rapidnovor.com2023-06-21T10:56:04-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Polyclonal antibody, Proteomics, REpAb, Technology|

All Things Proteomics Newsletter.

All Posts.

Alpaca Antibody Discovery and Characterization with Polyclonal Sequencing, SPR and HDX-MS

Illia icherednychenko@rapidnovor.com2023-11-14T11:28:27-05:00Categories: Case Studies|Tags: Antibody characterization, Antibody discovery, REpAb, Technology|

Affinity Maturation: How The Immune System Gets Smarter Over Time

Genya Gorshtein2023-10-27T09:29:24-04:00Categories: Articles|Tags: Antibody discovery, Featured, Learning|

The Basics of Protein and Antibody Glycosylation

Genya Gorshtein2023-10-20T15:23:18-04:00Categories: Articles|Tags: Antibody characterization, Featured, GLYscan, Learning|

New Antibody Characterization Essentials from Discovery to Clinic

Genya Gorshtein2023-10-27T10:34:59-04:00Categories: Webinars|Tags: Antibody characterization, De novo sequencing, Featured, HDX-MS, Monoclonal antibody, Recombinant expression, REmAb, SPR, Technology|

Antibody Developability: Sequence and Structure Impacts Antibody Aggregation

Genya Gorshtein2023-09-12T16:43:59-04:00Categories: Articles|Tags: HDX-MS, Learning, REmAb|

Latest Advancements in Antibody Engineering – Bispecifics, Diagnostic Controls, and More

Illia icherednychenko@rapidnovor.com2023-11-09T13:19:41-05:00Categories: Webinars|Tags: AbEng, Antibody engineering, Antibody generation, Application, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

Confirming the Binding Site Between Cellular DNA Repair Proteins with HDX-MS

Genya Gorshtein2023-08-11T10:04:11-04:00Categories: Case Studies|Tags: Antibody characterization, Featured, HDX-MS, Technology|

Antibody Discovery from a Chicken Polyclonal Mixture

Genya Gorshtein2023-07-28T14:59:31-04:00Categories: Case Studies|Tags: Antibody discovery, Antibody generation, De novo sequencing, Featured, REpAb, Technology|

Antibody Discovery Dead Ends and New Approaches

Illia icherednychenko@rapidnovor.com2023-08-24T15:35:59-04:00Categories: Webinars|Tags: Antibody engineering, Antibody generation, Application, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

Primary and Secondary Antibodies in Immunoassays

Genya Gorshtein2023-07-07T10:10:31-04:00Categories: Articles|Tags: General knowledge, Learning, MATCHmAb, REmAb|

Single-Molecule Characterization of Subtype-Specific β1 Integrin Mechanics

Mingjie Xie2023-11-09T13:27:20-05:00Categories: Case Studies|Tags: AbEng, Antibody engineering, Antibody generation, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

CAR-iNKT Cells Targeting Clonal TCRVβ Chains as a Precise Strategy to Treat T Cell Lymphoma

Mingjie Xie2023-11-09T13:27:52-05:00Categories: Case Studies|Tags: AbEng, Antibody engineering, Antibody generation, CAR-T, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

Antibody Drug Discovery and Development

Mingjie Xie2023-06-09T11:40:17-04:00Categories: Articles|Tags: Antibody characterization, De novo sequencing, Featured, HDX-MS, Learning, Monoclonal antibody, Proteomics, REmAb, SPR|

Breakthrough: Sequencing Functional Antibody Proteins Directly from Human Blood

Illia icherednychenko@rapidnovor.com2023-07-18T16:41:53-04:00Categories: News|

Tackling Reproducibility in Life Sciences with Next Generation Protein Sequencing and Recombinant Expression

Genya Gorshtein2023-06-21T10:24:06-04:00Categories: Articles|Tags: Learning, Protein sequencing, Recombinant expression, REmAb, REpAb|

Rational Antibody Design and Engineering with Next Generation Protein Sequencing

Illia icherednychenko@rapidnovor.com2023-11-09T13:21:24-05:00Categories: Webinars|Tags: AbEng, Antibody engineering, Antibody generation, Application, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

Evaluation and Selection of a Lead Diabody for Interferon-γ PET Imaging

Mingjie Xie2023-06-21T11:04:08-04:00Categories: Case Studies|Tags: Antibody engineering, Antibody generation, Application, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

Functional Characterization of Therapeutic Antibodies

Mingjie Xie2023-05-15T11:02:52-04:00Categories: Articles|Tags: Antibody characterization, De novo sequencing, Featured, HDX-MS, Learning, Monoclonal antibody, Proteomics, REmAb, SPR|

Secure Full Antibody and Target IP Protection with Next Generation Protein Sequencing

Genya Gorshtein2023-06-21T10:20:38-04:00Categories: Articles|Tags: Application, De novo sequencing, HDX-MS, Learning, SPR|

Immunochemical Characterization of Therapeutic Antibodies

Mingjie Xie2023-09-07T13:06:03-04:00Categories: Articles|Tags: Antibody characterization, De novo sequencing, Featured, HDX-MS, Learning, Monoclonal antibody, Proteomics, SPR|

The Shortcut to Reliable Diagnostic, Control, and Assay Antibodies

Illia icherednychenko@rapidnovor.com2023-06-21T10:15:28-04:00Categories: Webinars|Tags: Application, De novo sequencing, Featured, Learning, Monoclonal antibody, Polyclonal antibody, Recombinant expression, REmAb, REpAb, Technology|

Exploring the Sheep (Ovis aries) Immunoglobulin Repertoire by Next Generation Sequencing

Mingjie Xie2023-06-21T11:03:47-04:00Categories: Case Studies|Tags: Antibody discovery, Application, Featured, Monoclonal antibody, Next-generation sequencing, Polyclonal antibody, Sheep, Technology, Vet med|

Navigating Intellectual Property Protection for Antibodies

Illia icherednychenko@rapidnovor.com2023-06-21T10:21:38-04:00Categories: Webinars|Tags: Antibody characterization, Antibody kinetics, Application, Featured, HDX-MS, Learning, Monoclonal antibody, REmAb, SPR|

Rapid Novor’s Blood Test for Multiple Myeloma Monitoring is CLIA Certified for Clinical Use in the US

Illia icherednychenko@rapidnovor.com2023-06-27T10:48:12-04:00Categories: News|

Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization

Illia icherednychenko@rapidnovor.com2023-11-03T19:41:45-04:00Categories: News|

Talk to Our Scientists.

We Have Sequenced 8000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Talk to Our Scientists.

We Have Sequenced 8000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Talk to our scientists. We have sequenced over 8000 antibodies and we are eager to help you.